- Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients With Attention Deficit Hyperactivity Disorder
-
Kim JH, Park S, Lee YJ
- KMID: 2541507
- J Korean Acad Child Adolesc Psychiatry.
- 2023 Apr;34(2):125-132.
- doi: 10.5765/jkacap.220040
Objectives: This study investigated the relationship between suicidal behavior and the use of methylphenidate (MPH) or atomoxetine (ATX) in patients with attention deficit hyperactivity disorder (ADHD). Methods: The Preferred Reporting Items... -
- CITED
-
- Close
- SHARE
-
- Close
- Atomoxetine and Fluoxetine Activate AMPK-ACC-CPT1 Pathway in Human SH-SY5Y and U-87 MG Cells
-
Jeon S, Park JE, Do YH, Santos R, Lee SM, Kim BN, Cheong JH, Kim Y
- KMID: 2540696
- Psychiatry Investig.
- 2023 Mar;20(3):212-219.
- doi: 10.30773/pi.2022.0255
Objective Atomoxetine and fluoxetine are psychopharmacologic agents associated with loss of appetite and weight. Adenosine monophosphate-activated protein kinase (AMPK) is the cellular energy sensor that regulate metabolism and energy, being... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Atomoxetine for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Alpha-synucleinopathies: A Systematic Review of Randomized Controlled Trials and a Focus-Group Discussion
-
Jung YJ, Kim A, Okamoto LE, Hong WH
- KMID: 2539614
- J Clin Neurol.
- 2023 Mar;19(2):165-173.
- doi: 10.3988/jcn.2022.0018
Background and Purpose Neurogenic orthostatic hypotension (nOH) is one of the most important nonmotor symptoms in patients with α-synucleinopathies. Atomoxetine is a selective norepinephrine transporter blocker that is a treatment option... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial
-
Shim Sh, Woo YS, Kim JS, Heo IS, Yoon Hj, Sung HM, Lee J, Bahk WM
- KMID: 2526856
- Clin Psychopharmacol Neurosci.
- 2022 Feb;20(1):143-153.
- doi: 10.9758/cpn.2022.20.1.143
Objective: This study aimed to compare the efficacy and safety of atomoxetine (ATX) and OROS methylphenidate (MPH) as adjunctive to selective serotonin reuptake inhibitors (SSRIs) in adults with attention-deficit hyperactivity... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined Medication with Stimulants and Non-stimulants for Attention-deficit/hyperactivity Disorder
-
Bahn GH, Seo K
- KMID: 2522975
- Clin Psychopharmacol Neurosci.
- 2021 Nov;19(4):705-711.
- doi: 10.9758/cpn.2021.19.4.705
Objective: To study the efficiency and indication of combined medication with a stimulant and non-stimulant for attention-deficiency/hyperactivity disorder (ADHD), herein, the authors examined children and adult patients with ADHD. Methods: Subjects... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacological treatment for attention deficit hyperactivity disorder in adults
-
Kweon K
- KMID: 2510609
- J Korean Med Assoc.
- 2021 Jan;64(1):49-56.
- doi: 10.5124/jkma.2021.64.1.49
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by attention deficits, hyperactivity, and impulsivity. In the past, ADHD was considered to be limited to children and adolescents. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Brief Replication Study Comparing Stimulants and Non-Stimulants for Attention-Deficit/Hyperactivity Disorder Treatment with a Focus on the Compliance, Efficacy, and Satisfaction
-
Roh H, Kim B
- KMID: 2510457
- J Korean Acad Child Adolesc Psychiatry.
- 2021 Jan;32(1):10-16.
- doi: 10.5765/jkacap.200024
Objectives: The aim of this study was to compare the compliance, efficacy, and satisfaction associated with methylphenidate and atomoxetine for treating attention-deficit/hyperactivity disorder (ADHD). Methods: The subjects were 44 patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of Neutropenia with Valproate, Antipsychotics, and ADHD Medication Combination Treatment in Children and Adolescents
-
Oh Y, Joung YS, Choi J
- KMID: 2504362
- J Korean Med Sci.
- 2020 Jul;35(28):e226.
- doi: 10.3346/jkms.2020.35.e226
This study's aim was to investigate whether the incidence of neutropenia was higher in subjects who received a combination pharmacotherapy with valproate (VPA), antipsychotics (APs), and attention deficit hyperactivity disorder... -
- CITED
-
- Close
- SHARE
-
- Close
- Methylphenidate-induced Exacerbation of Chorea in a Child Resolved with Switching to Atomoxetine
-
Ekinci O, Yaşöz C, Baş SA, Ekinci N, Doğan
- KMID: 2502222
- Clin Psychopharmacol Neurosci.
- 2020 May;18(2):327-330.
- doi: 10.9758/cpn.2020.18.2.327
Choreiform movements have been reported with stimulant medications, especially in adults. There is only limited evidence on the management of such reactions in children with attention deficit hyperactivity disorder. Hereby,... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Children and Adolescents with Epilepsy with Atomoxetine
-
Park KJ, Ahn H, Yum MS, Ko TS, Kim HW
- KMID: 2501459
- Psychiatry Investig.
- 2020 May;17(5):412-416.
- doi: 10.30773/pi.2019.0287
Objective The objective of this study was to assess the effectiveness and safety of atomoxetine in Korean children and adolescents with epilepsy. Methods We retrospectively reviewed the electronic medical records of... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical and Neuropsychological Factors Associated with Treatment Response and Adverse Events of Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder
-
Park KJ, Kim HW
- KMID: 2448881
- J Korean Acad Child Adolesc Psychiatry.
- 2019 Apr;30(2):74-82.
- doi: 10.5765/jkacap.180030
OBJECTIVES: The objective of this study was to investigate clinical and neuropsychological factors associated with treatment response and adverse events of atomoxetine in children with attention-deficit/hyperactivity disorder (ADHD) in Korea. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacotherapy for attention-deficit/hyperactivity disorder
-
Kim B
- KMID: 2431994
- J Korean Med Assoc.
- 2019 Jan;62(1):49-55.
- doi: 10.5124/jkma.2019.62.1.49
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder defined by impairing levels of inattention, disorganization, and/or hyperactivity-impulsivity. ADHD often persists into adulthood, with resultant impairments of social, academic and occupational functioning.... -
- CITED
-
- Close
- SHARE
-
- Close
- Patterns and Persistence of Pharmacotherapy for Children and Adolescents with Attention Deficit Hyperactivity Disorder in South Korea
-
Lee KE, Je NK
- KMID: 2438547
- Korean J Clin Pharm.
- 2018 Sep;28(3):216-223.
- doi: 10.24304/kjcp.2018.28.3.216
OBJECTIVE: This study aimed to assess treatment persistence in Korean children and adolescents with attention deficit hyperactivity disorder (ADHD) and the factors influencing their adherence to ADHD pharmacotherapy. METHODS: The study... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Atomoxetine on Height and Weight in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review
-
Kweon K, Yoon JS, Park KJ, Kim SO, Choi JH, Kim HW
- KMID: 2428890
- Psychiatry Investig.
- 2018 Jun;15(6):649-654.
- doi: 10.30773/pi.2018.02.25.1
OBJECTIVE: We aimed to investigate the long-term effects of atomoxetine on growth in Korean children and adolescents with attention-deficit/hyperactivity disorder (ADHD). METHODS: The medical records of 82 subjects (mean age, 9.0±2.0... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors that Affect the Adherence to ADHD Medications during a Treatment Continuation Period in Children and Adolescents: A Nationwide Retrospective Cohort Study Using Korean Health Insurance Data from 2007 to 2011
-
Bhang SY, Kwack YS, Joung YS, Lee SI, Kim B, Sohn SH, Chung US, Yang J, Hong M, Bahn GH, Choi HY, Oh IH, Lee YJ, Hwang JW
- KMID: 2371795
- Psychiatry Investig.
- 2017 Mar;14(2):158-165.
- doi: 10.4306/pi.2017.14.2.158
OBJECTIVE: Several factors, such as male gender, older age, type of insurance, comorbid conditions, and medication type, have been associated with attention-deficit/hyperactivity disorder (ADHD) medication adherence rates, but the results... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database
-
Bhang SY, Hwang JW, Kwak YS, Joung YS, Lee S, Kim B, Sohn SH, Chung US, Yang J, Hong M, Bahn GH, Choi HY, Oh IH, Lee YJ
- KMID: 2373758
- J Korean Med Sci.
- 2016 Aug;31(8):1284-1291.
- doi: 10.3346/jkms.2016.31.8.1284
We evaluated the differences in utilization patterns including persistence and adherence among medications in children and adolescents with attention deficit hyperactivity disorder (ADHD). The current study was performed using data... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute Dystonia Following a Switch in Treatment from Atomoxetine to Low-dose Aripiprazole
-
Başay O, Basay BK, Öztürk O, Yüncü Z
- KMID: 2170993
- Clin Psychopharmacol Neurosci.
- 2016 May;14(2):221-225.
- doi: 10.9758/cpn.2016.14.2.221
The present report describes the cases of a 17-year-old male patient and a 13-year-old female patient who developed acute dystonia following the administration of low-dose aripiprazole (5 mg/day) after the... -
- CITED
-
- Close
- SHARE
-
- Close
- Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
-
Fujioka T, Takiguchi , Yatsuga C, Hiratani M, Hong KE, Shin MS, Cho S, Kosaka H, Tomoda A
- KMID: 2171005
- Clin Psychopharmacol Neurosci.
- 2016 Feb;14(1):79-87.
- doi: 10.9758/cpn.2016.14.1.79
OBJECTIVE: This study was conducted to validate the Advanced Test of Attention (ATA) of the visual attention version of Japanese children with attention deficit/hyperactivity disorder (ADHD) and to evaluate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011
-
Song I, Shin JY
- KMID: 2380734
- Epidemiol Health.
- 2016;38:e2016045.
- doi: 10.4178/epih.e2016045
OBJECTIVES: This study analyzed the prevalence of attention deficit hyperactivity disorder (ADHD) medication use among children and adolescents in Korea between January 1, 2007 and December 31, 2011. METHODS: Using the... -
- CITED
-
- Close
- SHARE
-
- Close
- Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report
-
Ram D, Patil S, Gowdappa B, Rajalakshmi I
- KMID: 2171037
- Clin Psychopharmacol Neurosci.
- 2015 Dec;13(3):321-323.
- doi: 10.9758/cpn.2015.13.3.321
Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic... -
- CITED
-
- Close
- SHARE
-
- Close
